SSCI, Inc. announces purchase of Symyx Technologies Discovery Tools for use in pharmaceutical development
“We believe the benefits of the Symyx system complement our approach to high-throughput, solid-state screening by offering significant time savings in liquid handling, design of experiments, and data management. We seek to marry the Symyx systems and technologies with methods and techniques developed at SSCI like capillary screening, wellplate-based transmission PXRD, and other proprietary experimental systems. It is clear from the data collected on hundreds of projects that this broad experimental approach will provide our clients with the highest probability of finding the most relevant forms for drug development.” said Dr. Pat Stahly, SSCI’s Chief Scientific Officer.
Paul Nowak, Symyx’s executive vice president and chief operating officer, commented, “Symyx is pleased to be working with SSCI, with the first implementation of our technologies by an organization fully dedicated to pharmaceutical solid-state research and contract drug improvement. This application is a strong complement to our ongoing business with pharmaceutical customers, and demonstrates the flexibility of our Discovery Tools and software to fit the needs of a growing base of customers.”
About SSCI, Inc.
Improving drug substance, drug product, and intellectual property for over a decade, SSCI is a comprehensive cGMP research and analytical service firm for the pharmaceutical, specialty, industrial, and fine chemical industries. SSCI focuses on the characterization and chemistry of solid materials for the purpose of helping our pharmaceutical industry clients accelerate the pace of drug development and improve the quality of the drugs that they offer to the world.
SSCI Inc. was founded in 1992 to provide professional development short courses and other educational services to the pharmaceutical industry. SSCI’s primary business now is cGMP contract research. SSCI’s services include Polymorph and Salt Screening and Selection, Form Selection, Crystallization of Difficult Materials, and related research activities.
